Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENA. [PDF]
Dermatol Ther (Heidelb)Augustin M +14 more
europepmc +1 more source
Multidimensional efficacy characterization of xeligekimab in moderate-to-severe plaque psoriasis: regional responses, treatment targets, and patient-reported outcomes from a randomized controlled trial. [PDF]
Front ImmunolHuang K, Zhao Y, Yang C, Zhang J.
europepmc +1 more source
Secukinumab-Induced Delayed Behçet-Like Reaction in a Patient with Plaque Psoriasis: A Case Report. [PDF]
Clin Cosmet Investig DermatolWei Y, Zhang P, Chuan J, Ye J, Liu T.
europepmc +1 more source
The sliding cupping therapy as an alternative strategy for treating plaque psoriasis: A randomized controlled trial. [PDF]
Medicine (Baltimore)Liu J +6 more
europepmc +1 more source
Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study. [PDF]
An Bras DermatolEngin B +6 more
europepmc +1 more source
IL-36-Driven Inflammation in Generalized Pustular Psoriasis: Immunological Insights from Plaque Psoriasis and Implications for Targeted Therapy. [PDF]
Int J Mol SciAndrzejczak K +5 more
europepmc +1 more source
Psoriasis flare following tirzepatide initiation in a patient with plaque psoriasis in remission: A case report. [PDF]
JAAD Case RepNeptune Rosa JM +2 more
europepmc +1 more source
Perception and Satisfaction with Calcipotriol and Betamethasone Dipropionate PAD-Cream in Patients with Plaque Psoriasis: Results From a Survey. [PDF]
Dermatol Pract ConceptGisondi P +3 more
europepmc +1 more source